CRISPR/cas9 endonuclease-mediated genome editing is used to target exon 2. The founder contains a 108 nucleotide deletion (including the start codon. Western blot confirms the loss of isoform I. (J:338627)
查看原文 参与反馈
CRISPR/cas9 endonuclease-mediated genome editing is used to target exon 2. The founder contains a 108 nucleotide deletion (including the start codon. Western blot confirms the loss of isoform I. (J:338627)